Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells

被引:41
作者
Thomas, CY
Chouinard, M
Cox, M
Parsons, S
Stallings-Mann, M
Garcia, R
Jove, R
Wharen, R
机构
[1] Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA
[2] Univ S Florida, Mol Oncol Program, H Lee Moffit Canc Ctr & Res Inst, Tampa, FL USA
[3] Mayo Clin Jacksonville, Mayo Med Sch, Dept Neurosurg, Jacksonville, FL 32224 USA
[4] Univ Florida, Mol Oncol Program, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
关键词
receptor protein-tyrosine kinases; mitogen activated protein kinases;
D O I
10.1002/ijc.10880
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Overexpressed epidermal growth receptor factor receptors (EGFRs) are thought to contribute to the malignant phenotype of human glioblastomas (GBMs), but the mechanism is not well understood. We found that SKMG-3 cells, a rare GBM cell line that maintains EGFR gene amplification in vitro, produced high levels of EGFR protein. The cells also expressed the related receptors HER2/neu and HER4, but not HER3. Immunoblots and tryptic phosphopeptide maps showed that the SKMG-3 EGFRs were intact and functional and that a subset of these receptors were spontaneously autophosphorylated. EGF treatment stimulated phosphorylation of the EGFRs as well as the downstream effectors Erk, AKT1, stat3 and c-Cbl. Under minimal growth conditions, the unstimulated SKMG-3 cells contained constitutively phosphorylated Erk and AKT1 but no detectable stat3 DNA-binding complexes. The EGFR kinase inhibitor PD158780 reduced the constitutive phosphorylation of the receptor and Erk but not that of AKT1. In contrast, inhibition of phosphatidylinositol-3-kinase (PI3K) blocked the constitutive phosphorylation of Erk and AKT-1 but not the EGFR. We conclude that the SKMG-3 cells represent the subset of GBMs with amplified EGFR genes that overexpress intact receptors. The results also suggest that in some GBMs, signals from overexpressed EGFRs contribute to the constitutive phosphorylation of Erk, but these signals may not required for the constitutive activation of PI3K or AKT1. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:19 / 27
页数:9
相关论文
共 61 条
  • [31] ANALYSIS OF THE ROLE OF THE SHC AND GRB2 PROTEINS IN SIGNAL-TRANSDUCTION BY THE V-ERBB PROTEIN
    MEYER, S
    LABUDDA, K
    MCGLADE, J
    HAYMAN, MJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (05) : 3253 - 3262
  • [32] Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas
    Mishima, K
    Higashiyama, S
    Asai, A
    Yamaoka, K
    Nagashima, Y
    Taniguchi, N
    Kitanaka, C
    Kirino, T
    Kuchino, Y
    [J]. ACTA NEUROPATHOLOGICA, 1998, 96 (04) : 322 - 328
  • [33] Multiple positive and negative regulators of signaling by the EGF-receptor
    Moghal, N
    Sternberg, PW
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) : 190 - 196
  • [34] Differential modulation of mitogen-activated protein (MAP) kinase extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor
    Montgomery, RB
    Moscatello, DK
    Wong, AJ
    Cooper, JA
    Stahl, WL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) : 30562 - 30566
  • [35] Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor
    Moscatello, DK
    Holgado-Madruga, M
    Emlet, DR
    Montgomery, RB
    Wong, AJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) : 200 - 206
  • [36] Nagane M, 1996, CANCER RES, V56, P5079
  • [37] Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases
    Nagane, M
    Levitzki, A
    Gazit, A
    Cavenee, WK
    Huang, HJS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (10) : 5724 - 5729
  • [38] A MUTANT EPIDERMAL GROWTH-FACTOR RECEPTOR COMMON IN HUMAN GLIOMA CONFERS ENHANCED TUMORIGENICITY
    NISHIKAWA, R
    JI, XD
    HARMON, RC
    LAZAR, CS
    GILL, GN
    CAVENEE, WK
    HUANG, HJS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (16) : 7727 - 7731
  • [39] The ErbB signaling network: receptor heterodimerization in development and cancer
    Olayioye, MA
    Neve, RM
    Lane, HA
    Hynes, NE
    [J]. EMBO JOURNAL, 2000, 19 (13) : 3159 - 3167
  • [40] OSHEROV N, 1993, J BIOL CHEM, V268, P11134